Latest news
Biocodex Microbiota Foundation announces open call for projects for $50,000 2026 USA Microbiome Research Grant
The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has opened applications for its 2026 USA research grant. The $50,000 grant will be awarded to a U.S.-based investigator studying the gut microbiota and its relationship to human health and disease.
Huayunuo approval positions China at forefront of viral hepatitis innovation, says GlobalData
Huahui Health has recently secured conditional approval from China for Huayunuo (Libevitug Injection), marking it as the first domestically developed monoclonal antibody (mAb) drug for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis.
World Water Day 2026: Book your free place on our Gender Equality and Water webinar
Applied Microbiology International will hold a free webinar on ‘Gender Equality and Water’ to mark World Water Day 2026 - March 18 2026. We’ll be joined by Professor Jiménez Cisneros, an expert in water management, sanitation and sustainable development, and Professor Lyla Mehta, an expert on water, sanitation, gender and development.
Virgin olive oil protects cognitive health through the gut microbiota
A new study reveals that people who consumed virgin olive oil rather than refined olive oil showed improved cognitive function and greater diversity in their gut microbiota, which is an important marker of intestinal and metabolic health.
Novel camel antimicrobial peptides show promise against drug-resistant bacteria
Researchers have identified three novel antimicrobial peptides (AMPs) from dromedary camels that effectively target multidrug-resistant bacteria, offering potential alternatives to conventional drugs.
Scrub typhus a threat in the home, study in South India finds
Most human scrub typhus infections could occur inside villages rather than during agricultural work, suggests new research conducted with the help of communities living in Tamil Nadu.
Novel camel antimicrobial peptides show promise against drug-resistant bacteria
Researchers have identified three novel antimicrobial peptides (AMPs) from dromedary camels that effectively target multidrug-resistant bacteria, offering potential alternatives to conventional drugs.
Scrub typhus a threat in the home, study in South India finds
Most human scrub typhus infections could occur inside villages rather than during agricultural work, suggests new research conducted with the help of communities living in Tamil Nadu.
Elevated E. coli, staph still detected in Potomac river 4 weeks after sewage spill
Nearly a month after a wastewater pipe broke and spewed hundreds of millions of gallons of raw sewage into the Potomac River just north of Washington, D.C., the latest water testing results continue to show high levels of E. coli and S. aureus, including antibiotic-resistant MRSA.
Huayunuo approval positions China at forefront of viral hepatitis innovation, says GlobalData
Huahui Health has recently secured conditional approval from China for Huayunuo (Libevitug Injection), marking it as the first domestically developed monoclonal antibody (mAb) drug for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis.
Scaling up: Fungus plays key role in crafting spalted wood
A new standardized, scalable process deploys a fungal pest of deciduous trees to create a unique woodworking product - spalted wood, with its distinctive etched black markings.
Valneva provides update on recommendations for use of IXCHIQ® in UK
Valneva SE has announced that following a review of the benefits and risks of the Company’s single-dose chikungunya vaccine, IXCHIQ® , the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine.
New single-cell transcriptomic clock reveals intrinsic and systemic T cell aging in COVID-19 and HIV
Scientists developed a new single-cell transcriptomic clock called T immune cell transcriptomic clock (Tictock) to measure aging in specific immune cells. They found that in patients with acute Covid-19, the infection increased the biological age of naïve CD8 T cells.
Novel vaccine protects against C. diff disease and recurrence
A novel vaccination approach cleared the harmful gut bacterium Clostridioides difficile in an animal model of infection. An experimental vaccine administered to the mucosal lining of the colon protected against illness, death, tissue damage and infection recurrence.
Scientists develop first-of-its-kind antibody to block Epstein Barr virus
Using mice with human antibody genes, scientists have developed new genetically human monoclonal antibodies that prevent two key antigens on the surface of the Epstein Barr virus (EBV) from binding to and entering human immune cells.
Biocodex Microbiota Foundation announces open call for projects for $50,000 2026 USA Microbiome Research Grant
The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has opened applications for its 2026 USA research grant. The $50,000 grant will be awarded to a U.S.-based investigator studying the gut microbiota and its relationship to human health and disease.
World Water Day 2026: Book your free place on our Gender Equality and Water webinar
Applied Microbiology International will hold a free webinar on ‘Gender Equality and Water’ to mark World Water Day 2026 - March 18 2026. We’ll be joined by Professor Jiménez Cisneros, an expert in water management, sanitation and sustainable development, and Professor Lyla Mehta, an expert on water, sanitation, gender and development.
Webinar: What does it mean when environmental microbiomes are described as resilient?
Environmental microbiomes are often described as ‘resilient’ - but what does that even mean? A free upcoming webinar and coffee hour delivered by Dr Ashley Shade, as part of the Microbes and Social Equity 2026 Speaker Series, aims to find out.